Gautam Mitra

746 total citations
36 papers, 561 citations indexed

About

Gautam Mitra is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Gautam Mitra has authored 36 papers receiving a total of 561 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in Gautam Mitra's work include Protein purification and stability (11 papers), Virus-based gene therapy research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Gautam Mitra is often cited by papers focused on Protein purification and stability (11 papers), Virus-based gene therapy research (5 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Gautam Mitra collaborates with scholars based in United States and India. Gautam Mitra's co-authors include John L. Lundblad, Gopalan Soman, Paul K. Ng, JayA. Levy, James W. Bloom, Wanda K. Hartmann, Charles R. Wilke, Steven L. Giardina, Xiao Yang and Milton M. Mozen and has published in prestigious journals such as The Lancet, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Gautam Mitra

33 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gautam Mitra United States 14 251 152 109 94 89 36 561
John L. Lundblad United States 11 111 0.4× 113 0.7× 61 0.6× 96 1.0× 37 0.4× 23 384
Jenson Lim United Kingdom 15 220 0.9× 252 1.7× 32 0.3× 93 1.0× 58 0.7× 23 679
Pak‐Leong Lim Hong Kong 11 272 1.1× 85 0.6× 81 0.7× 22 0.2× 27 0.3× 27 512
Fangfang Chen China 14 329 1.3× 303 2.0× 36 0.3× 44 0.5× 155 1.7× 27 880
Mehdi Forouzandeh Iran 14 518 2.1× 87 0.6× 126 1.2× 12 0.1× 132 1.5× 29 817
Dennis R. Goulet United States 11 410 1.6× 167 1.1× 423 3.9× 23 0.2× 66 0.7× 19 786
Qingchao Li China 14 266 1.1× 62 0.4× 33 0.3× 19 0.2× 59 0.7× 59 646
James B. Hamburger United States 7 236 0.9× 90 0.6× 42 0.4× 8 0.1× 43 0.5× 12 458
P.L. Masson Belgium 14 138 0.5× 107 0.7× 96 0.9× 42 0.4× 33 0.4× 30 464
M Kawagoe Japan 16 114 0.5× 200 1.3× 51 0.5× 43 0.5× 14 0.2× 38 664

Countries citing papers authored by Gautam Mitra

Since Specialization
Citations

This map shows the geographic impact of Gautam Mitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gautam Mitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gautam Mitra more than expected).

Fields of papers citing papers by Gautam Mitra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gautam Mitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gautam Mitra. The network helps show where Gautam Mitra may publish in the future.

Co-authorship network of co-authors of Gautam Mitra

This figure shows the co-authorship network connecting the top 25 collaborators of Gautam Mitra. A scholar is included among the top collaborators of Gautam Mitra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gautam Mitra. Gautam Mitra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Hua, Yueqing Xie, Andrew Burnette, et al.. (2012). Purification of clinical-grade disulfide stabilized antibody fragment variable—Pseudomonas exotoxin conjugate (dsFv-PE38) expressed in Escherichia coli. Applied Microbiology and Biotechnology. 97(2). 621–632. 13 indexed citations
2.
Soman, Gopalan, et al.. (2011). Comparison of GD2 binding capture ELISA assays for anti-GD2-antibodies using GD2-coated plates and a GD2-expressing cell-based ELISA. Journal of Immunological Methods. 373(1-2). 181–191. 10 indexed citations
3.
Yang, Xiaoyi, Raymond D. Harris, Steven L. Giardina, et al.. (2008). Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay. Journal of Virological Methods. 155(1). 44–54. 24 indexed citations
4.
Hartmann, Wanda K., et al.. (2004). Characterization and analysis of thermal denaturation of antibodies by size exclusion high-performance liquid chromatography with quadruple detection. Analytical Biochemistry. 325(2). 227–239. 58 indexed citations
5.
Little, Stephen F., et al.. (2003). Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants. Vaccine. 21(21-22). 3011–3018. 43 indexed citations
6.
Yang, Xiao, et al.. (2003). Development of a quantitative antigen-specific cell-based ELISA for the 7G7/B6 monoclonal antibody directed toward IL-2Rα. Journal of Immunological Methods. 277(1-2). 87–100. 11 indexed citations
7.
Mitra, Gautam, et al.. (1996). Protein Purification in Preparative Scale of Mammalian Cell Culture–Derived Products. Annals of the New York Academy of Sciences. 782(1). 422–431. 4 indexed citations
8.
Ng, Phillip & Gautam Mitra. (1994). Removal of DNA contaminants from therapeutic protein preparations. Journal of Chromatography A. 658(2). 459–463. 12 indexed citations
9.
Galloway, Cynthia J., et al.. (1994). Inactivation of Hepatitis C Virus in Low pH Intravenous Immunoglobulin. Biologicals. 22(1). 13–19. 32 indexed citations
10.
Bloom, James W., et al.. (1993). Epitope mapping and functional analysis of three murine IgG1 monoclonal antibodies to human tumor necrosis factor- alpha .. The Journal of Immunology. 151(5). 2707–2716. 6 indexed citations
11.
Galloway, Cynthia J., et al.. (1991). Monoclonal anti-tumor necrosis factor (TNF) antibodies protect mouse and human cells from TNF cytotoxicity. Journal of Immunological Methods. 140(1). 37–43. 15 indexed citations
12.
Bloom, James W., et al.. (1989). Detection and reduction of Protein A contamination in immobilized Protein A purified monoclonal antibody preparations. Journal of Immunological Methods. 117(1). 83–89. 41 indexed citations
13.
Mitra, Gautam, et al.. (1988). Inactivation of viruses in therapeutic products derived from human plasma. The American Journal of Medicine. 84(6). 87–90. 6 indexed citations
14.
Mitra, Gautam, et al.. (1986). Elimination of infectious retroviruses during preparation of immunoglobulins. Transfusion. 26(4). 394–397. 52 indexed citations
15.
Mitra, Gautam & Michael Wong. (1986). Use of lipid solvents for viral inactivation in factor VIII concentrates. Biotechnology and Bioengineering. 28(2). 297–300. 3 indexed citations
16.
Mitra, Gautam, E. T. Hall, & Indrajit Mitra. (1986). Application of immobilized heparins for isolation of human antithrombin III. Biotechnology and Bioengineering. 28(2). 217–222. 7 indexed citations
17.
Mitra, Gautam & Michael H. Coan. (1984). Preparation and characterization of a soluble dextran α1 proteinase inhibitor complex. Biotechnology and Bioengineering. 26(5). 452–456. 3 indexed citations
18.
Levy, JayA., et al.. (1984). RECOVERY AND INACTIVATION OF INFECTIOUS RETROVIRUSES ADDED TO FACTOR VIII CONCENTRATES. The Lancet. 324(8405). 722–723. 53 indexed citations
19.
Mitra, Gautam, et al.. (1982). Kinetics of thermal denaturation of antithrombin III. Biotechnology and Bioengineering. 24(1). 97–107. 6 indexed citations
20.
Lundblad, John L., et al.. (1976). 透析ろ過(diafiltration)による溶質の最適分離条件. 11(5). 499–502. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026